Author

Tuğçe Cinek

Observed name: Tugce Cinek

Institutions: Istanbul Health and Technology University, Istanbul Technical University, Istanbul University

Observed institutions: Istanbul Health and Technology University, Istanbul Technical University, Istanbul University

ORCID: 0000-0001-5625-0189

Observed ORCID: 0000-0001-5625-0189

OpenAlex ID: A5013465815

New 2-indolinone-indole hybrid compounds carrying a benzoyl moiety as tyrosine kinase inhibitors

2025 · Merve Camcı-Eren, Tuğçe Cinek, et al. · Bioorganic Chemistry · 9

Novel 1-benzyl-2-indolinone indole hybrids as tyrosine kinase inhibitors: Design, synthesis, and biological activity evaluation

2025 · Gökçe Cihan-Üstündağ, Tuğçe Cinek, et al. · European Journal of Medicinal Chemistry · 5

The Effect of Radiofrequency Exposure on the Cytotoxic Activity of Sunitinib and a Novel Sunitinib-Class Compound 4, in Colorectal Cancer Cells

2026 · Ayse Erol Bozkurt, Mediha Suleymanoglu, et al. · International Journal of Molecular Sciences · 1

Histone deacetylase inhibitors providing an epigenetic treatment in cancer

2021 · Tuğçe Cinek, Nilgün Karalı · Istanbul Journal of Pharmacy · 1

Synthesis, Moleculer Modeling, and Carbonic Anhydrase Inhibitor Effects of Novel 1‐(1‐benzyl‐2‐oxoindolin‐3‐ylidene)‐4‐(3‐sulfamoylphenyl)thiosemicarbazides

2026 · Çağla Begüm Apaydın, Tuğçe Cinek, et al. · ChemMedChem

Novel 1-benzyl-oxindole indole hybrids targeting PDGFR-β, SRC, and c-MET signaling and inducing caspase-3-dependent apoptosis in pancreatic cancer cells

2026 · Tuğçe Cinek, Merve Yildirim, et al. · European Journal of Medicinal Chemistry

New 2-Indolinone-Indole Hybrid Compounds Carrying a Benzoyl Moiety as Tyrosine Kinase Inhibitors

2025 · Merve CAMCI, Tuğçe Cinek, et al. · SSRN Electronic Journal

Works count: 7

Citation count: 16

H-index: 2

I10-index: